Radical Hysterectomy for Stage IB1 vs IB2 Carcinoma of the Cervix: Does the New Staging System Predict Morbidity and Survival?

By Finan M.A.   deCesare S.   Fiorica J.V.   Chambers R.   Hoffman M.S.   Kline R.C.   Roberts W.S.   Cavanagh D.  

Gynecologic Oncology, Vol. 62, Iss. 2, 1996-08 ,pp. : 139-147

Academic Press

Access to resources Recommend Favorite

MIB-1 Labeling Index as a Prognostic Indicator for Survival in Patients with FIGO Stage IB Squamous Cell Carcinoma of the Cervix

By Ho D.M.-T.   Hsu C.-Y.   Chiang H.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 97-102

Elsevier

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy in Stage IB2 Squamous Cell Carcinoma of the Cervix

By Serur E.   Mathews R.P.   Gates J.   Levine P.   Maiman M.   Remy J.C.  

Gynecologic Oncology, Vol. 65, Iss. 2, 1997-05 ,pp. : 348-356

Elsevier

Access to resources Recommend Favorite

Application of Tumor Markers CEA, TPA, and SCC-Ag in Patients with Low-Risk FIGO Stage IB and IIA Squamous Cell Carcinoma of the Uterine Cervix

By Juang C.-M.   Wang P.-H.   Yen M.-S.   Lai C.-R.   Ng H.-T.   Yuan C.-C.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 103-106

Elsevier

Access to resources Recommend Favorite

Altered CD44 Variant 6 Expression in FIGO Stage IB Cervical Carcinoma

By Ayhan A.   Baykal C.   Al A.   Ayhan A.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 569-574

Elsevier

Access to resources Recommend Favorite